New release of ICBRR questions answers with braindumps

All of us facilitate thousands associated with prospects pass the particular ICBRR exams with the ICBRR real questions and practice check. We have a large number associated with successful testimonials. The practice questions are reliable, inexpensive, up to time, and valid. killexams.com questions answers are newest updated on a normal basis and ICBRR braindumps are usually released periodically.

Exam Code: ICBRR Practice exam 2022 by Killexams.com team
International Certificate in Banking Risk and Regulation (ICBRR)
GARP International Practice Test
Killexams : GARP International practice test - BingNews https://killexams.com/pass4sure/exam-detail/ICBRR Search results Killexams : GARP International practice test - BingNews https://killexams.com/pass4sure/exam-detail/ICBRR https://killexams.com/exam_list/GARP Killexams : ASE offering free practice tests through January

LEESBURG, Va. — As the National Institute for Automotive Service Excellence (ASE) concludes its 50th anniversary year, the association is is offering service professionals the opportunity to take an official ASE practice test at no charge.

To receive a free practice test voucher, individuals should login or create a myASE account at my.ase.com. From the store tab, they should click on ASE practice test Vouchers and then practice test Voucher. Check the box for practice test voucher, enter the code ASE50th and click apply to get the free voucher.

An email containing the voucher code will be sent to the email address in the participants myASE account. The deadline to request a free practice test voucher is Jan. 31.

Once an automotive service professional receives their practice test voucher, it can be redeemed at asepractice.com and can be used for the A1-A8, C1, G1, L1, P2, T2, T4, T6 or T8 practice tests.

Individuals have 60 days from the date they redeem a voucher code for a practice test to complete their review test. It is possible to stop at any point and return later to complete the test by entering the same code.

Tue, 06 Dec 2022 03:56:00 -0600 en text/html https://www.tirebusiness.com/service-zone/ase-offering-free-practice-tests-through-january
Killexams : How to Use practice tests to Study for the LSAT No result found, try new keyword!Likewise, it’s a bad idea to take the LSAT without first training with real practice tests. That said, very few athletes run daily marathons. Instead, they vary their training with shorter ... Tue, 01 Nov 2022 19:56:00 -0500 text/html https://www.usnews.com/education/blogs/law-admissions-lowdown/articles/how-to-use-practice-tests-to-study-for-the-lsat Killexams : Growth at a Reasonable Price (GARP): Definition and Strategy

What Is Growth at a Reasonable Price (GARP)?

Growth at a reasonable price (GARP) is an equity investment strategy that seeks to combine tenets of both growth investing and value investing to select individual stocks. GARP investors look for companies that are showing consistent earnings growth above broad market levels while excluding companies that have very high valuations. The overarching goal is to avoid the extremes of either growth or value investing; this typically leads GARP investors to growth-oriented stocks with relatively low price/earnings (P/E) multiples in normal market conditions.

Key Takeaways

  • Growth at a reasonable price (GARP) is an equity investment strategy that combines growth and value investing attributes.
  • GARP investors focus on companies with earnings growth above broad market levels but without extremely high valuations.
  • GARP stocks are growth-orientated with relatively low price/earnings (P/E) multiples.
  • GARP investors typically use the price/earnings growth (PEG) ratio to make investment choices, seeking companies with a PEG of 1 or less.
  • Instead of selecting individual securities, investors can apply the GARP strategy through index funds that track the S&P 500 GARP Index.

Understanding Growth at a Reasonable Price (GARP)

GARP investing was popularized by legendary Fidelity manager Peter Lynch. While the style may not have rigid boundaries for including or excluding stocks, a fundamental metric that serves as a solid benchmark is the price/earnings growth (PEG) ratio.

The PEG shows the ratio between a company's P/E ratio (valuation) and its expected earnings growth rate over the next several years. A GARP investor would seek out stocks that have a PEG of 1 or less, which shows that P/E ratios are in line with expected earnings growth. This helps to uncover stocks that are trading at reasonable prices.

In a bear market or other downturn in stocks, one could expect the returns of GARP investors to be higher than those of pure growth investors but subpar to strict value investors who generally purchase shares at P/Es under broad market multiples.

GARP Investors vs. Value Investors

Value investors try to buy stocks that are on sale. Value investors look for stocks at bargain prices for a) a larger chance to earn a future profit and b) less risk of losing your money if the stock doesn’t perform well as you had anticipated. This fundamental principle is called the margin of safety.

Value investors also do not buy into the efficient-market hypothesis, which postulates that stock prices already take the full spread of company, industry, and market information into account. Value investors believe that it’s possible to pick overvalued or undervalued stocks relative to their current market price. Value investors may perform a discounted cash flows analysis (DCF) to determine a stock’s intrinsic value.

Famous value investors include Warren Buffett, CEO, and chair of Berkshire Hathaway, which grew to become one of the largest publicly traded companies in the world.

GARP Strategy

One of the most straightforward ways to utilize the GARP strategy is by investing in an index fund that utilizes the strategy. This removes having to analyze your own stocks and come up with investments that fit the criteria of a GARP investment.

Standard and Poor's has created the S&P 500 GARP Index, which is an index that tracks "companies with consistent fundamental growth, reasonable valuation, solid financial strength, and strong earning power."

One fund that tracks the S&P 500 GARP Index is the Invesco S&P 500 GARP ETF (SPGP). It is an exchange traded fund that aims to invest 90% of its assets into the securities that make up the S&P 500 GARP Index.

The fund's largest holdings are in healthcare (29.39%) followed by information technology stocks (21.40%). Financials is the next heavily invested sector at 17.28%. The smallest invested sector is consumer staples at 3.71%. Above that is communication services at 5.61%. Well-known stocks include Meta (formerly Facebook), Adobe, and Cigna. The fund also comes with a low expense ratio of 0.36%, making it an affordable investment choice.

Fri, 18 Nov 2022 06:00:00 -0600 en text/html https://www.investopedia.com/terms/g/garp.asp
Killexams : 4 GARP Stocks to Scoop Up for Maximum Returns

Growth at a reasonable price or GARP is an excellent strategy to earn quick profits from investments. The GARP approach helps identify stocks that are priced below the market or any reasonable target determined by fundamental analysis.

The strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. GARP stocks have solid prospects in terms of cash flow, revenues, earnings per share (EPS) and others.

Therefore, a portfolio created on the basis of the GARP strategy contains stocks that offer the best value and growth investing. RPM International RPM, W.W. Grainger GWW, Grand Canyon Education LOPE and Texas Roadhouse TXRH are some GARP stocks that hold promise.

GARP Metrics — Mix of Growth & Value Metrics

The GARP strategy seeks to offer an ideal investment by utilizing the best features of both value and growth investing. Investors adopting the GARP approach will prefer to buy stocks that are priced below the market or any reasonable target determined by fundamental analysis. The stocks have solid prospects in terms of cash flow, revenues, EPS and others.

Growth Metrics

A strong earnings growth history and impressive earnings prospects are the main concepts that GARP investors borrow from the growth investing strategy. However, instead of super-normal growth rates, pursuing stocks with a more stable and reasonable growth rate is a tactic of GARP investors. Hence, growth rates between 5% and 20% are considered ideal under the GARP strategy.

Another growth metric considered by both growth and GARP investors is return on equity (ROE). GARP investors look for strong and higher ROE than the industry average to identify superior stocks. Moreover, stocks with a positive cash flow find precedence under the GARP plan.

Value Metrics

GARP investing prioritizes one of the popular value metrics — the price-to-earnings (P/E) ratio. Though the investing style picks stocks with higher P/E ratios than value investors, it avoids companies with extremely high P/E ratios. The price-to-book value (P/B) ratio is also considered.

Using the GARP principle, we have run a screen to identify stocks that should offer solid returns in the near term.

Screening Parameters

Along with the criteria discussed in the above section, we have considered a Zacks Rank #1 (Strong Buy) or 2 (Buy).

Last 5-year EPS & projected 3-5-year EPS growth rates between 5% and 20% (Strong EPS growth history and prospects ensure improving business.)

ROE (over the past 12 months) greater than the industry average (Higher ROE compared to the industry average indicates superior stocks.)

P/E and P/B ratios less than the M-industry average (P/E and P/B ratios less than that of the industry indicate that the stocks are undervalued.)

Here are four stocks that made it through the screen:

RPM International manufactures and markets high-performance coatings, sealants and specialty chemicals, primarily for maintenance and improvement applications. RPM currently sports a Zacks Rank #1. You can see the complete list of today's Zacks #1 Rank stocks here.

RPM has a trailing four-quarter earnings surprise of 7.34%, on average. The Zacks Consensus Estimate for RPM's fiscal 2023 earnings has moved 2.4% north to $4.60 per share over the past 30 days.

W.W. Grainger is a broad-line, business-to-business distributor of maintenance, repair and operating products and services, operating primarily in North America, Japan and the U.K. The company currently carries a Zacks Rank #2.

W.W. Grainger has a trailing four-quarter earnings surprise of 10.1%, on average. The Zacks Consensus Estimate for W.W. Grainger’s 2022 earnings has moved 4.1% north to $29.31 per share over the past 30 days.

Grand Canyon Education is an accredited provider of online post-secondary education services focused on offering graduate and undergraduate degree programs in its core disciplines of education, business and healthcare.  The company currently carries a Zacks Rank #2.

Grand Canyon Education has a trailing four-quarter earnings surprise of 4.79%, on average. The Zacks Consensus Estimate for LOPE's 2022 earnings has moved 3.9% north to $5.85 per share over the past 30 days.

Texas Roadhouse is a full-service, casual dining restaurant chain, which offers an assortment of specially seasoned and aged steaks on the premises and cooked to order over open grills. The company currently carries a Zacks Rank #2.

Texas Roadhouse has a trailing four-quarter earnings surprise of 11.24%, on average. The Zacks Consensus Estimate for 2022 earnings has moved 4.6% north to $4.07 per share over the past 30 days.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks' portfolios and strategies are available at: https://www.zacks.com/performance.

Want the latest recommendations from Zacks Investment Research? Today, you can obtain 7 Best Stocks for the Next 30 Days. Click to get this free report

Texas Roadhouse, Inc. (TXRH) : Free Stock Analysis Report

W.W. Grainger, Inc. (GWW) : Free Stock Analysis Report

Grand Canyon Education, Inc. (LOPE) : Free Stock Analysis Report

RPM International Inc. (RPM) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Wed, 23 Nov 2022 02:48:00 -0600 en-US text/html https://finance.yahoo.com/news/4-garp-stocks-scoop-maximum-131201111.html
Killexams : Scoop Up These 4 GARP Stocks to Net Handsome Returns

If you are looking for a profitable portfolio of stocks offering the best value and growth investing, try the growth at a reasonable price or GARP strategy.

The strategy helps investors gain exposure to undervalued stocks with impressive prospects. Unlike a blend strategy, a portfolio that uses GARP investing is expected to include stocks that offer the best of both value and growth investing.  W.W. Grainger GWW, Ameriprise Financial AMP, Grand Canyon Education LOPE and Texas Roadhouse TXRH are some GARP stocks that hold promise.

GARP Metrics — Mix of Growth & Value Metrics

The GARP strategy seeks to offer an ideal investment by utilizing the best features of both value and growth investing. Investors adopting the GARP approach prefer buying stocks priced below the market or any reasonable target determined by fundamental analysis. These stocks also have solid prospects in terms of cash flow, revenues, earnings per share (EPS) and so on.

Growth Metrics

Both a strong earnings growth history and impressive earnings prospects are the main concepts that GARP investors borrow from the growth investing strategy. However, instead of super-normal growth rates, pursuing stocks with a more stable and reasonable growth rate is a tactic of GARP investors. Hence, growth rates between 5% and 20% are considered ideal under the GARP strategy.

Another growth metric that both growth and GARP investors consider is the return on equity (ROE). GARP investors look for a strong and higher ROE than the industry average to identify superior stocks. Moreover, stocks with positive cash flows find precedence under the GARP plan.

Value Metrics

GARP investing prioritizes the popular value metrics — the price-to-earnings (P/E) ratio and the price-to-book (P/B) ratio. Though this investing style picks stocks with higher P/E ratios compared to value investors, it avoids companies with extremely high P/E ratios.

Using the GARP principle, we ran a screen to identify stocks that should offer solid returns in the near term.

Screening Parameters

Along with the criteria discussed in the above section, we have considered a Zacks Rank #1 (Strong Buy) or 2 (Buy).

Last 5-year EPS & projected 3-5-year EPS growth rates between 5% and 20% (Strong EPS growth history and prospects ensure improving business.)

ROE (over the past 12 months) greater than the industry average (Higher ROE than the industry average indicates superior stocks.)

P/E and P/B ratios less than the M-industry average (P/E and P/B ratios less than that of the industry indicate that the stocks are undervalued.)

Here are four of the five stocks that made it through the screen:

W.W. Grainger is a broad-line, business-to-business distributor of maintenance, repair and operating products and services, operating primarily in North America, Japan and the U.K. The company currently carries a Zacks Rank #2.  You can see the complete list of today's Zacks #1 Rank stocks here.

W.W. Grainger has a trailing four-quarter earnings surprise of 10.1%, on average. The Zacks Consensus Estimate for W.W. Grainger’s 2022 earnings has moved 4.4% north to $29.31 per share over the past 60 days.

Ameriprise Financial is a financial services company, which offers financial planning and advice via its broad range of products and services to customers. The company currently carries a Zacks Rank #2.

Ameriprise Financial has a trailing four-quarter earnings surprise of 4.83%, on average. The Zacks Consensus Estimate for AMP’s 2022 earnings has moved 2.5% north to $24.56 per share over the past 60 days.

Grand Canyon Education is an accredited provider of online post-secondary education services focused on offering graduate and undergraduate degree programs in its core disciplines of education, business and healthcare.  The company currently carries a Zacks Rank #2.

Grand Canyon Education has a trailing four-quarter earnings surprise of 4.79%, on average. The Zacks Consensus Estimate for LOPE's 2022 earnings has moved 3.9% north to $5.85 per share over the past 60 days.

Texas Roadhouse is a full-service, casual dining restaurant chain, which offers an assortment of specially seasoned and aged steaks on the premises and cooked to order over open grills. The company currently carries a Zacks Rank #2.

Texas Roadhouse has a trailing four-quarter earnings surprise of 11.24%, on average. The Zacks Consensus Estimate for 2022 earnings has moved 5.4% north to $4.07 per share over the past 60 days.

Get the remaining stock on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back testing software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks' portfolios and strategies are available at: https://www.zacks.com/performance.

Want the latest recommendations from Zacks Investment Research? Today, you can obtain 7 Best Stocks for the Next 30 Days. Click to get this free report

Ameriprise Financial, Inc. (AMP) : Free Stock Analysis Report

Texas Roadhouse, Inc. (TXRH) : Free Stock Analysis Report

W.W. Grainger, Inc. (GWW) : Free Stock Analysis Report

Grand Canyon Education, Inc. (LOPE) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Tue, 06 Dec 2022 00:43:00 -0600 en-US text/html https://www.yahoo.com/entertainment/scoop-4-garp-stocks-net-132801024.html
Killexams : A Post-Thanksgiving Feast Of GARP Stocks

GARP stands for growth at a reasonable price. This is the middle ground between value investing (buying what’s unpopular) and growth investing (looking for the next Nvidia).

I’m a dyed-in-the-wool value guy. But once a year in this column, I recommend a few GARP stocks.

To simplify the world, let’s say that value stocks generally sell for less than 15 times the company’s profits per share, or less. Growth stocks generally sell for 20 times earnings or more. In the middle, on GARP ground, are stocks selling for 16 to 19 times earnings. Here are five GARP stocks I like now.

Cisco Systems CSCO , a computer-networking company, was one of the hottest growth stocks of the late 1990s. Now it’s a much more mature company, but still a good one in my opinion.

The company earned $2.82 a share in its latest fiscal year (ended in July). Analysts expect earnings to rise in the current year and the next two years after that, hitting $4.03 a share in fiscal 2025.

With that kind of growth, I’d expect this stock to sell for 20 times earnings or more, but in fact its multiple is 17. Tech stocks in general have been smashed this year, and I believe Cisco—down 23% year to date—is one of many stocks in the sector that are attractive now.

Another technology stock I like is Texas Instruments TXN . Based in Dallas, the company is one of the largest semiconductor manufacturers in the world, and consistently one of the most profitable. It has earned at least 15% on stockholders’ equity in each of the past 15 years, and more than 30% in seven of those years. In the past four quarters, the figure was a towering 65%.

Texas Instruments is the world’s largest maker of analog chips, used to modulate continuously variable signals such as sound and power. It gets about 95% of its revenue from semiconductors and about 5% from calculators. The stock sells for about 19 times earnings.

A mid-sized company that has grown fast is Stride LRN , an online education company. During the pandemic, it served homebound students from kindergarten through seniors in high school. With progress against Covid-19, that business is fading, but career education and adult education are growing.

My reasoning here is crude, but I think right. People are very busy, and yet educational credentials are essential for career advancement. That gives an edge to online learning programs, especially those (like most of Stride’s) that are sponsored by recognized schools. The stock is at 17 times earnings.

Darling Ingredients (DAR) and recycles various food waste materials such as used cooking oil and bakery remnants. It transforms these into animal feed, food ingredients (such as gelatin) and fertilizer. It has shown a profit in each of the past 15 years and profits have accelerated lately.

The company has made a few acquisitions recently, which has caused it to run up its debt. Debt is still less than stockholders’ equity, but only narrowly so. The stock sells for 16 times earnings—but only 11 times the earnings analysts expect in 2023.

Regeneron Pharmaceuticals REGN , based in Tarrytown, New York, is a biotech company that already has several products on the market. Its biggest sellers are the eye medication Eylea (about $9 billion per year in sales), Regen-Cov for Covid-19 (more than $7 billion) and Dupixent which treats several conditions, including eczema and esophagitis (about $6 billion).

Regeneron’s 10-year sales growth rate is about 30% per year. Considering that, I’d say the stock is modestly priced at a little over 15 times earnings.

This is the 22nd column I’ve written about GARP stocks. The average one-year return on my recommendations in this series has been 10.6%, a bit better than the 9.2% average for the Standard & Poor’s 500 Total Return Index over the same periods.

Thirteen of the 21 columns have been profitable, and 12 have beaten the S&P 500. Bear in mind that my column results are hypothetical and shouldn’t be confused with results I obtain for clients. Also, past performance doesn’t predict the future.

Last year’s column had the second-worst results in the entire series. All five of my selections declined, with an average loss of 29.96%. The worst performer was T. Rowe Price Group Inc., down 38%. For comparison, the S&P 500 Total Return Index was down 13.13%.

Disclosure: I own Texas Instruments personally and for almost all of my clients.

Mon, 28 Nov 2022 01:45:00 -0600 John Dorfman en text/html https://www.forbes.com/sites/johndorfman/2022/11/28/a-post-thanksgiving-feast-of-garp-stocks/
Killexams : HUB INTERNATIONAL LAUNCHES PROFESSIONAL & EXECUTIVE RISK PRACTICE

New HUB Practice Formalizes HUB's Specialization in Professional and Executive Liability Insurance Products, Risk Solutions and Claims Services

CHICAGO, Nov. 9, 2022 /CNW/ -- Hub International Limited (HUB), a leading global insurance brokerage and financial services firm, announced today the launch of its Professional & Executive Risk (ProEx) Specialty Practice. The new practice brings together over 100 HUB specialists with executive liability, professional liability, tech/cyber, and transactional risk insurance placement capabilities, and specialized risk and claims services. Together they'll advise clients on navigating the changing risk landscape to protect their personal and organization's reputation and assets from complex insurance issues that arise from claims and litigation exposures.

Hub International Logo (PRNewsfoto/Hub International Limited)

"The HUB ProEx practice continues our strategy to provide the best resources, specialists and expertise, for public, private and nonprofit clients who are experiencing greater exposure and risk every day," said Marc Cohen, CEO and President of HUB International. "HUB's ProEx team has proven expertise in the professional, financial and executive risk areas, advising C-suite clients on their potential exposures and creating innovative insurance and risk solutions for their needs."

HUB ProEx will be led by David Garrigus who will manage the overall North American practice and growth strategy. Garrigus has nearly 20 years of experience as a broker focused on executive management and professional liability of large and complex risks. He joined HUB in 2019 as Executive Vice President and as the Regional Management Liability, Professional Liability, Cyber, and Transactional Risk Practice Leader. He will lead the practice that includes experienced former professional and executive risk attorneys to serve as a resource for HUB throughout North America.

"Today, organizations are exposed to a more complex and costly legal and regulatory environment, and the risks are only going to get more complicated," said Garrigus. "Our ProEx team has been helping these organizations delivering more comprehensive solutions that provide better placement, analytics and insights to protect them from existing and evolving threats."

HUB's ProEx practice works with clients throughout North America providing insurance, risk advice and claims advocacy, particularly in four product segments:

  • Executive Liability – Directors & Officers Liability (D&O), Fiduciary Liability, Employment Practices Liability (EPL), Crime, and Kidnap, Ransom, and Extortion

  • Professional Liability – Errors & Omissions (E&O) including Lawyers Professional, Architects & Engineers Professional, and Healthcare Professional Liability

  • Transactional Risk - Representations & Warranties, Tax Indemnity, Litigation & Contingent Risk; and

  • Cyber, Technology E&O, and Intellectual Property.

Additionally, the ProEx practice will work alongside HUB's established Specialty and industry practices to develop industry-specific placements, and advisory risk and claims guidance based on industry analytics and insights.

Learn more about the ProEx Specialty practice, here.

About HUB International

Headquartered in Chicago, Illinois, Hub International Limited is a leading full-service global insurance broker and financial services firm providing risk management, insurance, employee benefits, retirement and wealth management products and services. With more than 15,000 employees in offices located throughout North America, Hub's vast network of specialists brings clarity to a changing world with tailored solutions and unrelenting advocacy, so clients are ready for tomorrow. For more information, visit Hub Media Center.

MEDIA CONTACTS:
Marni Gordon
Phone: 312-279-4601
Marni.gordon@hubinternational.com
Jessica Wiltse
Phone: 312-596-7573
jessica.wiltse@hubinternational.com

Cision

View original content to obtain multimedia:https://www.prnewswire.com/news-releases/hub-international-launches-professional--executive-risk-practice-301672565.html

SOURCE Hub International Limited

Cision

View original content to obtain multimedia: http://www.newswire.ca/en/releases/archive/November2022/09/c0292.html

Tue, 08 Nov 2022 23:05:00 -0600 en-US text/html https://www.yahoo.com/now/hub-international-launches-professional-executive-130000857.html
Killexams : ATRenew Is An Attractive Green GARP Stock

belterz/E+ via Getty Images

Investors looking to find the next high-growth star should consider ATRenew Inc. (NYSE:RERE). This company recently reported its Q3 numbers. The non-GAAP EPS of $0.06 beats by $0.04. The Q3 revenue of $356.5 million is +29.2% Y/Y. but it missed by $16.72 million. The revenue guidance for Q4 is between 2,930 million and 3,090 million renminbi. This translates to $410.34 to $432.75 million. ATRenew's Q4 2021 revenue was only $383 million.

My Hypothesis

A big beat on Q4 revenue and EPS could help RERE rebound above $3. It is the universal problem of Chinese companies that they do not get enough coverage. I hope that by publishing here at Seeking Alpha, ATRenew gets into the radar of growth-minded investors.

My buy thesis is that ATRenew is on track to sustain its TTM revenue CAGR of 37.75%. In my book, any company that can achieve greater than 20% annual sales growth is a legit growth stock.

This excellent growth performance of ATRenew is likely why four Wall Street analysts rate RERE as a buy. Their average price target for this stock is $11.63. ATRenew stock is currently trading at less than $1.80. The almost 600% upside potential that Wall Street analysts are predicting for RERE is worth betting on.

Very Bullish Wall Street analysts for ATRenew

Seeking Alpha Premium

This Christmas shopping season will most probably boost sales of new and pre-owned smartphones, tablets, laptops, and other electronic gadgets. ATRenew will be collecting and recycling more used gadgets after this Christmas-boosted quarter. I expect Q4 revenue to be higher than $430 million. Going forward, fiscal year 2022's annual revenue could be as high as $1.45 billion.

Why You Should Go Long

RERE's stock is down -3.47% on the first day after its Q3 ER. The YTD performance of RERE is now -72.3%. My takeaway is that ATRenew's stock is already a viable candidate for bottom-fishing growth investors. The huge price decline has made RERE very affordable. You can see from the screenshot below that RERE's TTM Price/Sales valuation is now only 0.32. This is 61.79% lower than the sector average of 0.85.

Relative undervaluation of ATRenew

Seeking Alpha Premium

The big decline from its 52-week high of $8.29 has also lowered RERE's TTM Price/Book valuation to just 0.47. This is 77.29% lower than the sector average of 2.06. The significant undervaluation of ATRenew is a buy opportunity. I opine any high-growth company that trades at less than 1x Price/Sales is a bargain.

The growth potential of ATRenew is obvious. Established in 2011, ATRenew operates 1,804 brick & mortar retail stores. Those stores trade and sell used pre-owned gadgets.

ATRenew company is helping reduce the bad environmental impact of electronic or e- waste. The e-waste recycling business through barter, swapping, reselling of used gadgets is a $99.67 billion business that is growing at 16.2% CAGR.

The retail industry for refurbished smartphones alone was worth $50 billion last year. The market for refurbished personal computers was worth $9.1 billion last year.

growing resale market for used PCs

Statista Premium

ATRenew is a leader in a new business category called recommerce. Instead of governments spending too much money on disposing e-waste products on landfill sites, ATRenew's commendable core business is to extend the usability of used electronic products.

Please refer to the chart below. From 2019's revenue of $564.69 million, ATRenew's expected 2022 revenue is $1.52 billion. The projected 2023 revenue is $2.05 billion. This rapid annual sales growth is your most important metric when evaluating RERE's investment quality.

high revenue growth makes RERE a buy

Seeking Alpha Premium

Is RERE A Safe Bet?

There is an inherent risk in investing Chinese firms listed in NYSE or NASDAQ. Fortunately, the U.S. government has approved the Holding Foreign Companies Accountable Act or HFCAA. This law requires all foreign-owned companies that are listed in U.S. stock markets to be more transparent in their financial records. Any foreign company in violation of the HFCAA rules could risk getting delisted from NASDAQ or NYSE.

On the other hand, getting delisted from U.S. stock markets is not going to kill ATRenew as a company. It can list itself in Hong Kong or U.K.

I checked. ATRenew is not in the list of 271 Chinese companies that are in danger of being delisted.

As for financial health, RERE's total cash reserves as of most accurate quarter amounted to $320.94 million. This is 10x greater than its total debt of $27.38 million. Short-sellers are not attacking RERE. There's negligible 1.08% shorted of the total RERE shared floated.

ATRenew has enough cash reserves

Seeking Alpha Premium

Final Thoughts

I hope this buy thesis will renew the interest of former bulls for ATRenew. This stock used to trade above $7 twelve months ago. If you have idle cash and you are bold enough to invest in Chinese growth stocks, go long on RERE while it trades below $2. Any growth stock that trades below 1x P/S ratio is a golden bargain. RERE is a GARP stock at 0.32x P/S.

My fearless forecast is that ATRenew can sustain a 3-year revenue CAGR greater than 30%. This is due to the lack of a serious rival inside China's huge 309 billion yuan ($43.7 billion) market for pre-owned electronic gadgets. We also cannot dismiss the possibility that ATRenew could expand to India, Asia, and Latin America.

My takeaway is that international expansion could accelerate ATRenew's ascent to profitability. Seeking Alpha Quant expects RERE to have a fiscal 2023 forward non-GAAP P/E valuation of 7.54x. My guesstimate is that ATRenew could finish F2023 with a non-GAAP EPS of $0.30. Multiply that by 7.54, we get $2.26. That is my humble Seeking Alpha Quant AI-infused 12-month price target for RERE.

There's also the possibility that ATRenew could expand to a recommerce of pre-owned brand-name clothing, jewelries, and other accessories. It is my sublime takeaway that the more than 1,804 ATRenew stores could also eventually buy and sell pre-owned Prada or Louis Vuitton products.

ATRenew can easily tap that $29.13 billion industry for pre-owned luxury goods. This expansion market is something that ATRenew should learn from this thesis.

Thu, 24 Nov 2022 02:57:00 -0600 en text/html https://seekingalpha.com/article/4560390-atrenew-attractive-green-garp-stock
Killexams : Do Expired COVID Tests Work? Here’s the Deal, According to Experts

We’ve gotten to the point in the COVID-19 pandemic where you’re probably not stressed every single day about getting the virus—the wide availability of COVID-19 vaccines and effective treatments have thankfully made that possible. And, with that, you likely have some tests around your place for the just-in-case that may have been sitting there for a while. Here’s the thing, though: They can expire. Yep, there is a COVID test expiration date printed on your package that you may not even realize is there.

Many COVID-19 tests last for just a year or so, but the odds are high that you’ll need to use your at some point. That may or may not be before the expiration date stamped on your package passes. So…do expired COVID tests work, or do you need to toss what you thought was a perfectly good test? It’s actually a little complicated. Here’s what you need to know.

So, do expired COVID tests work?

Yes and no. To fully understand that, it’s important to explain how COVID-19 tests get an expiration date in the first place. “When tests are developed, the company will assess the test over time to make sure it’s performing with the quality standards intended,” says Thomas Russo, M.D., a professor and the chief of infectious diseases at the University at Buffalo in New York. “Whatever time frame they assess it for is the expiration date that will go on that test.”

This “doesn’t necessarily mean that the test won’t perform for a longer period of time,” Dr. Russo says—it’s just the amount of time that the test has been assessed for and what is authorized or approved by the Food and Drug Administration (FDA).

Older tests are more likely to have shorter expiration dates because there were time pressures to get tests out earlier in the pandemic, when they were first developed, and only so much time since they had been created to test how long they were good for, Dr. Russo says. “However, companies kept assessing the tests over time,” he says.

As a result, “many manufacturers have received shelf life extensions by the FDA,” says infectious disease expert Amesh A. Adalja, M.D., a senior scholar at the Johns Hopkins Center for Health Security.

The FDA has a list online of authorized home COVID-19 tests, along with links to “updated expiration dates” so you can check to see if your test’s expiration date has been extended.

“If you have a test and it’s ‘expired’ based on what the package says, it may or may not be the most correct expiration date,” Dr. Russo says.

What happens if you use an expired test?

Again, the expiration dates are a reflection of how long the company that manufactured the test found that it was good for—or the period of time in which they were able to assess the test. With that, there’s a chance that your test will still be good beyond the expiration date listed. “Most tests will still perform past their expiration date for several weeks,” Dr. Adalja says.

If the test has truly expired “you are more likely to get a false negative,” says Jamie Alan, Ph.D., associate professor of pharmacology and toxicology at Michigan State University. “The test might be negative because the reagents or ‘ingredients’ are past their shelf life and are not working as they should,” she explains. “They are likely good past their expiration date, although how long I cannot say with any degree of certainty.”

If you have symptoms of COVID-19 and the only test you have at home is expired, Alan says you could try it. “If you get a positive, you are probably positive,” she says. “If you get a negative, it would be good to follow up with another test, either a PCR test or another rapid at-home test.”

Why do COVID tests expire?

COVID tests contain specific reagents (aka ingredients) that react with the virus, or lack thereof, from your swab, Alan explains. “These ingredients do not work forever,” she says. “This is true for medications, lab materials, and food.”

How do I know if my BinaxNOW is expired?

BinaxNOW is one of the most popular home tests out there, and it typically has an expiration date stamped on the back of the box. But, again, that may not be the most up-to-date expiration date for your test.

If you have a test with an expired date on the package, check out the FDA’s list of updated expiration dates for BinaxNOW tests to see if it’s been extended. Just keep in mind that you’ll need to have your box’s lot number handy.

But, if your test is expired—both on the box and per the FDA’s updated dating—and you want to be sure you’re getting an accurate reading, Dr. Russo says it’s “probably best to not use that test.”

This article is accurate as of press time. However, as the COVID-19 pandemic rapidly evolves and the scientific community’s understanding of the novel coronavirus develops, some of the information may have changed since it was last updated. While we aim to keep all of our stories up to date, please visit online resources provided by the CDC, WHO, and your local public health department to stay informed on the latest news. Always talk to your doctor for professional medical advice.

Tue, 06 Dec 2022 14:44:00 -0600 en-us text/html https://www.prevention.com/health/a42086541/expired-covid-tests/
ICBRR exam dump and training guide direct download
Training Exams List